These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21270096)

  • 21. Definition of chronic kidney disease after uninephrectomy in living donors: what are the implications?
    Barri YM; Parker T; Daoud Y; Glassock RJ
    Transplantation; 2010 Sep; 90(5):575-80. PubMed ID: 20562736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional renal reserve capacity in different stages of chronic kidney disease.
    Barai S; Gambhir S; Prasad N; Sharma RK; Ora M
    Nephrology (Carlton); 2010 Apr; 15(3):350-3. PubMed ID: 20470306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS
    Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
    Wesson DE; Buysse JM; Bushinsky DA
    J Am Soc Nephrol; 2020 Mar; 31(3):469-482. PubMed ID: 31988269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
    Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
    Dhaun N; Ferro CJ; Davenport AP; Haynes WG; Goddard J; Webb DJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3228-34. PubMed ID: 17556408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
    Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass.
    Wesson DE; Simoni J
    Kidney Int; 2009 May; 75(9):929-35. PubMed ID: 19190678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bicarbonate therapy for prevention of chronic kidney disease progression.
    Łoniewski I; Wesson DE
    Kidney Int; 2014 Mar; 85(3):529-35. PubMed ID: 24107852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease.
    Goraya N; Simoni J; Sager LN; Mamun A; Madias NE; Wesson DE
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F502-F511. PubMed ID: 31215805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inaccuracies in estimated glomerular filtration rate in one Australian renal centre.
    Brown MA; Pirabhahar S; Kelly JJ; Mangos GJ; Mackenzie C; McConachie P; Janssen J; Smart RC
    Nephrology (Carlton); 2011 Jul; 16(5):486-94. PubMed ID: 21352419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
    Leoncini G; Viazzi F; Rosei EA; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
    J Hypertens; 2010 Jan; 28(1):156-62. PubMed ID: 19915481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
    Serrano A; Huang J; Ghossein C; Nishi L; Gangavathi A; Madhan V; Ramadugu P; Ahya SN; Paparello J; Khosla N; Schlueter W; Batlle D
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):105-12. PubMed ID: 17200050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
    Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
    Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.